Last updated: 2026-09-16 13:20:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Satellos Bioscience Inc. (MSLE) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $9.36, with a market capitalisation of $207.71M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.44 to $13.39. This page covers its latest market performance, valuation, price trends and company information.
$207.71M | |
$9.40 | |
$13.39 | |
$5.44 | |
$9.36 | |
-- | |
53.82K | |
-- | |
$13.39 | |
$5.44 | |
-- | |
-- |
Satellos Bioscience Inc. (MSLE) is trading at $9.36 in pre-market trading as of 2026-09-16 11:46:00, up 0.04% ($0.00) from the previous close of $9.36
Pre-market trading shows how investors are pricing MSLE before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Satellos Bioscience Inc. (MSLE) moved from $8.97 to $9.36, representing a gain of 4.39% ($0.39).
The stock traded between $8.91 and $10.50 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 40.86 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 49.3%
MSLE is currently trading at $9.36, placing it 49.3% of the way from its 52-week low of $5.44 to its 52-week high of $13.39. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
| Employees | 21 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Satellos Bioscience Inc. (MSLE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.